OncoMed Pharmaceuticals, Inc.
OMED
OMED was delisted on the 22nd of April, 2019.
83 hedge funds and large institutions have $235M invested in OncoMed Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 14 reducing their positions, and 8 closing their positions.
214% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 14
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
6% more funds holding
Funds holding: 78 → 83 (+5)
7% more call options, than puts
Call options by funds: $1.51M | Put options by funds: $1.41M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less capital invested
Capital invested by funds: $257M → $235M (-$21.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
+$3.36M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.47M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$2.47M |
| 4 |
AC
Apex Capital
Orinda,
California
|
+$1.56M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.05M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$1.65M |
| 3 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$1.26M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$986K |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$478K |
OMED Hedge Fund Activity: Q2 2015 in Review
83 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in OncoMed Pharmaceuticals, Inc. (OMED) for Q2 2015, worth a combined $235M — down 8.4% from $257M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new OMED positions and 8 closed out — a net gain of 5 holders — while 44 added to existing stakes and 14 trimmed.
The largest buyer was Cannell & Co, adding an estimated $3.36M. The largest seller was Sectoral Asset Management, cutting an estimated $4.05M.
- 83 institutional investors held OncoMed Pharmaceuticals, Inc. (OMED) as of Q2 2015, up from 78 in Q1 2015.
- Funds reported $235M of OncoMed Pharmaceuticals, Inc. stock for Q2 2015, down 8.4% quarter-over-quarter.
- 13 funds opened new OncoMed Pharmaceuticals, Inc. positions in Q2 2015 and 8 closed out, a net change of +5 holders.
- The largest OncoMed Pharmaceuticals, Inc. buyer in Q2 2015 was Cannell & Co, an estimated $3.36M added.
- The largest OncoMed Pharmaceuticals, Inc. seller in Q2 2015 was Sectoral Asset Management, an estimated $4.05M sold.
Based on aggregated 13F filings for Q2 2015.